Literature DB >> 31376480

Stem cell factor and granulocyte colony-stimulating factor promote brain repair and improve cognitive function through VEGF-A in a mouse model of CADASIL.

Suning Ping1, Xuecheng Qiu1, Michele Kyle1, Karen Hughes1, John Longo1, Li-Ru Zhao2.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy (CADASIL) is a cerebral small vascular disease caused by NOTCH3 gene mutation in vascular smooth muscle cells (VSMCs), leading to ischemic stroke and vascular dementia. To date, the pathogenesis of CADASIL remains poorly understood, and there is no treatment that can slow the progression of CADASIL. Using a transgenic mouse model of CADASIL (TgNotch3R90C), this study reveals novel findings for understanding CADASIL pathogenesis that decreased cerebral vascular endothelial growth factor (VEGF/VEGF-A) is linked to reduced cerebral blood vessel density. Reduced endothelial cell (EC) proliferation and angiogenesis are seen in TgNotch3R90C mouse brain-isolated ECs. Decreased dendrites, axons, and synapses in the somatosensory and motor cortex layer 2/3 and in the hippocampal CA1, and reduced neurogenesis in both the subventricular zone and subgranular zone occur in 15-month-old TgNotch3R90C mice. These reductions in neuron structures, synapses, and neurogenesis are significantly correlated to decreased cerebral vasculature in the corresponding areas. Impaired spatial learning and memory in TgNotch3R90C mice are significantly correlated with the reduced cerebral vasculature, neuron structures, and synapses. Repeated treatment of stem cell factor and granulocyte colony-stimulating factor (SCF+G-CSF) at 9 and 10 months of age improves cognitive function, increases cerebral VEGF/VEGF-A, restores cerebral vasculature, and enhances regeneration of neuronal structures, synaptogenesis and neurogenesis in TgNotch3R90C mice. Pretreatment with Avastin, an angiogenesis inhibitor by neutralizing VEGF-A, completely eliminates the SCF+G-CSF-enhanced cognitive function, vascular and neuronal structure regeneration, synaptogenesis and neurogenesis in TgNotch3R90C mice. SCF+G-CSF-enhanced EC proliferation and angiogenesis in TgNotch3R90C mouse brain-isolated ECs are also blocked by Avastin pretreatment. These data suggest that SCF+G-CSF treatment may repair Notch3R90C mutation-damaged brain through the VEGF-A-mediated angiogenesis. This study provides novel insight into the involvement of VEGF/VEGF-A in the pathogenesis of CADASIL and sheds light on the mechanism underlying the SCF+G-CSF-enhanced brain repair in CADASIL. Published by Elsevier Inc.

Entities:  

Keywords:  CADASIL; G-CSF; SCF; VEGF; VEGF-A

Year:  2019        PMID: 31376480     DOI: 10.1016/j.nbd.2019.104561

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  6 in total

Review 1.  CADASIL from Bench to Bedside: Disease Models and Novel Therapeutic Approaches.

Authors:  Arianna Manini; Leonardo Pantoni
Journal:  Mol Neurobiol       Date:  2021-01-19       Impact factor: 5.590

2.  Stem Cell Factor in Combination With Granulocyte Colony-Stimulating Factor Protects the Brain From Capillary Thrombosis-Induced Ischemic Neuron Loss in a Mouse Model of CADASIL.

Authors:  Suning Ping; Xuecheng Qiu; Maria E Gonzalez-Toledo; Xiaoyun Liu; Li-Ru Zhao
Journal:  Front Cell Dev Biol       Date:  2021-01-12

Review 3.  Potential Mechanisms and Perspectives in Ischemic Stroke Treatment Using Stem Cell Therapies.

Authors:  Guoyang Zhou; Yongjie Wang; Shiqi Gao; Xiongjie Fu; Yang Cao; Yucong Peng; Jianfeng Zhuang; Junwen Hu; Anwen Shao; Lin Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-01

4.  VEGF Family Gene Expression as Prognostic Biomarkers for Alzheimer's Disease and Primary Liver Cancer.

Authors:  Kai Xu; Chuan-Ling Wu; Zhi-Xin Wang; Hai-Jiu Wang; Feng-Jiao Yin; Wen-Deng Li; Chu-Chu Liu; Hai-Ning Fan
Journal:  Comput Math Methods Med       Date:  2021-11-20       Impact factor: 2.238

5.  Ginsenoside Rg1 ameliorates blood-brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release.

Authors:  Kefeng Zhai; Hong Duan; Wei Wang; Siyu Zhao; Ghulam Jilany Khan; Mengting Wang; Yuhan Zhang; Kiran Thakur; Xuemei Fang; Chao Wu; Jianbo Xiao; Zhaojun Wei
Journal:  Acta Pharm Sin B       Date:  2021-03-19       Impact factor: 11.413

6.  Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation.

Authors:  Eri Takematsu; Miles Massidda; Jeff Auster; Po-Chih Chen; ByungGee Im; Sanjana Srinath; Sophia Canga; Aditya Singh; Marjan Majid; Michael Sherman; Andrew Dunn; Annette Graham; Patricia Martin; Aaron B Baker
Journal:  Nat Commun       Date:  2022-05-06       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.